Study of the Impact of Administering t the Scale of Brazelton on the Mother's Confidence in Her Newborn Born Premature at the Approach of Returning Home

In France, the last national perinatal survey show that 6.6% of live births are premature. For these infants, transfer in Neonatology sector may result in mother-child separation can last several weeks or months. This hospital can complicate the implementation of the attachment process that allows parents to recognize their children as their own, to gain confidence in their abilities to deal with them and establish a relationship with him.

A study of mothers of premature shows the interest of the Brazelton scale to help them identify the skills their child and adjust their own behavior.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infant, Premature Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Obstetric Labor, Premature Pregnancy Complications Premature Birth Urogenital Diseases

Age range

0 week–36 week

Sex eligibility

Male

Study type

Observational

Primary location

Limoges Hospital

Limoges, 87 042, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Mother: over the age of 18, affiliated to a health social security.
Newborn: born to a term of less than 36 S.A., hospitalized in neonatology, said leaving in three days.

Exclusion criteria

Mother :

Legally protected
Inability to understanding and monitoring of the protocol's terms (not master the French language, intellectual impairment, psychotic disorder ...)
Who have had a premature child born.

New born :

Opposition of one of the holders of parental authority to the award of the Brazelton Scale
Having withdrawal syndromes or malformation syndromes requiring oxygen therapy, gastrostomy or nasogastric tube
Twins and more.

Treatment and study plan

Brazelton scale

Other

Primary outcomes

Score GC (Global Confidence) of the MAPS scale (Mother Assessment Baby Scale)

Time frame: 2 hours

Secondary outcomes

Scale "EVA Anxiety"

Time frame: 1 hour

Sponsors and collaborators

Lead sponsor

University Hospital, Limoges

Other

Registry information

Acronym: BRAZMAMAN

Important dates

Study start: 2016
Primary completion: 2020
Study completion: 2020
First posted: Feb 3, 2016
Registry last updated: Feb 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed